This inventor holds 3 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: The University of Queensland, Texas A&M University System, University of California. Active years: 2008-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Brisbane, AU (2008)
- Carindale, AU (2019 - 2021)
Company Filing History:
3 out of 345 
1 out of 1,332 
1 out of 16,048 
Years Active: 2008-2021
Title: Trent Martin Woodruff: Innovator in Hematopoietic Stem Cell Mobilization
Introduction
Trent Martin Woodruff is a notable inventor based in Brisbane, Australia. He has made significant contributions to the field of biomedical research, particularly in the area of hematopoietic stem cell mobilization. With a total of 3 patents, his work has the potential to impact cancer treatment and other hyperproliferative disorders.
Latest Patents
One of his latest patents is titled "Mobilizing agents and uses therefor." This invention discloses the use of a complement 3a receptor (C3aR) antagonist and a mobilizer of hematopoietic stem cells and/or progenitor cells. It focuses on methods and compositions for stimulating or enhancing the development, mobilization, proliferation, and differentiation of a neutrophil-containing leukocyte population that inhibits the growth and spread of tumors. Another significant patent is the "Discovery of the first selective C5A receptor 2 (C5L2/C5AR2) ligands." This method involves selectively modulating the activity of C5a receptor 2 (C5aR2) by exposing it to a compound that selectively modulates C5aR2 compared to C5a receptor 1 (C5aR1). The compounds used in this method include peptide P32 or P59.
Career Highlights
Trent has worked with prestigious institutions such as the University of Queensland and the University of California. His research has focused on innovative methods to enhance the efficacy of treatments for various diseases, particularly those related to cancer.
Collaborations
Throughout his career, Trent has collaborated with esteemed colleagues, including Stephen Maxwell Taylor and David P Fairlie. These collaborations have contributed to the advancement of his research and the development of his patents.
Conclusion
Trent Martin Woodruff is a distinguished inventor whose work in hematopoietic stem cell mobilization holds promise for future medical advancements. His innovative patents and collaborations reflect his commitment to improving treatment options for patients with serious health conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile